M-Power Detroit Community Event On Health Empowerment
Focusing on awareness of multiple myeloma in the African American community and living a healthier life.
The M-Power Project realizes the IMF Diversity Initiative's vision, enhancing outcomes for African-American myeloma patients. Though the most common blood cancer in this group, with reduced barriers to diagnosis and treatment, they fare as well as or even better than white individuals. Empowering healthcare professionals, community leaders, neighborhoods, and families, M-Power raises myeloma awareness.
Watch Recordings From the Event:
Opening Remarks: Changing the Course of Myeloma in the Black Community
Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, provided an informative overview of myeloma during an M-Power Community Workshop in Tampa. Myeloma, a blood cancer, originates in the bone marrow and primarily affects plasma cells responsible for producing antibodies. Patients with myeloma often experience fatigue, pain, and anemia. Dr. Mikhael highlighted the significant advancements in myeloma treatments, including various drug classes, immunomodulatory drugs, and innovative therapies such as CAR T-cell therapy. The M-Power program strives to change the course of myeloma in the African-American community.
Understanding Multiple Myeloma: Simplifying the Science
In this informative video, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, breaks down the basics of multiple myeloma, explaining how it affects the body's plasma cells and its impact on health. From the role of red, white, and platelet cells to the challenges of diagnosis, Dr. Mikhael provides valuable insights into this often misunderstood disease. Discover why early detection is crucial, learn about the latest advancements in treatments, and explore how we're working towards improving outcomes and addressing health disparities.
Understanding Myeloma Disparities: Race, Diagnosis, and Survival
Chief Medical Officer of the International Myeloma Foundation Dr. Joseph Mikhael delves into the critical issue of myeloma disparities in African-American and Hispanic-American communities. Explore the factors contributing to delayed diagnosis, access to treatment, and survival outcomes. Learn about initiatives like the IMF M-Power Program, aimed at engaging, educating, and enhancing care to bridge these gaps and empower communities. Discover why addressing race in myeloma care is crucial for improving outcomes and how collaborative efforts can change the course of myeloma for all.
Revolutionizing Myeloma Treatment: Insights from Dr. Jeffrey Zonder
Join Dr. Jeffrey Zonder, myeloma physician at Karmanos Cancer Institute and leading authority in the field of myeloma treatment, for an in-depth discussion on the latest advancements in myeloma therapy. Learn about the evolution of treatment strategies over the past two decades, from induction chemotherapy to stem cell transplants and beyond. Discover how new therapies are reshaping the landscape of myeloma treatment, including innovative approaches like CAR T-cell therapy and bispecific antibodies. Don't miss this opportunity to gain valuable insights into the future of myeloma care from one of the foremost experts in the field.
Patient Stories & Lessons in Communication: Inspiring Testimonials
Join us at the 2023 Detroit M-Power workshop as two patients, Shirley Cotton and Robert Brooks, bravely share their journeys with multiple myeloma. From the challenges of diagnosis to navigating treatment options, their stories shed light on the importance of effective communication with healthcare providers. Gain insights into the significance of asking questions, understanding treatment processes, and exploring clinical trial opportunities. This compelling discussion highlights the need for patient empowerment and advocates for informed decision-making in managing multiple myeloma.
Empowering Myeloma Patients: Insights from Dr. Craig Cole
Join us for an insightful discussion with Dr. Craig Cole, a dedicated myeloma physician at Karmanos Cancer Institute, as he shares his personal journey and key lessons learned in patient empowerment. Discover why questioning your doctor and advocating for yourself are crucial steps in managing myeloma. Gain valuable insights to navigate your healthcare journey with confidence and empowerment. Watch now to learn more about myeloma and how you can become an active participant in your healthcare journey.
Effective Communication with Your Healthcare Team: Empower Yourself for Better Care
Donna Catamero, IMF Nurse Leadership Board (NLB) member and nurse practitioner (NP) at Mount Sinai Health System, teaches how to effectively communicate with your healthcare team and advocate for yourself and your family in this informative video. Discover strategies to overcome barriers to healthcare, including financial constraints and cultural differences. Get valuable tips on preparing for appointments, discussing symptoms, and understanding treatment plans. Take control of your health journey by becoming an active participant in your care. Watch now to empower yourself for better health outcomes.
Bridging Healthcare Disparities: What Research Says About Black Cancer Patients and Communication
Dive into the critical issue of disparities in healthcare, particularly in clinical communication, and discover how it impacts patient outcomes with Lauren Hamel, PhD, of Karmanos Cancer Institute. Join us as we explore research findings and interventions aimed at addressing these disparities, with a focus on improving communication between providers and black patients. Learn about question prompt lists (QPLs) and their significant role in empowering patients to ask important questions and make informed decisions during medical visits. Gain insights into the effectiveness of interventions and how they contribute to reducing healthcare disparities. Watch now to be part of the solution in bridging healthcare gaps and improving patient care.
With support from:
AbbVie, Amgen, Binding Site, Bristol Myers Squibb, GSK, Genentech, Johnson & Johnson, Karyopharm Therapeutics, and Sanofi
Collaborators:
Karmanos and Tabernacle
